Laurion Capital Management LP Karuna Therapeutics, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $783,566 - $1.07 Million	4,444 New	4,444 $963,000
Q3 2020 Nov 13, 2020	SELL	$71.31 - $109.74 $3.83 Million - $5.89 Million	-53,643 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$62.14 - $117.21 $5.8 Million - $10.9 Million	-93,364 Reduced 63.51%	53,643 $5.98 Million
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $8.88 Million - $17 Million	147,007 New	147,007 $10.6 Million
Q3 2019 Nov 13, 2019	SELL	$16.05 - $27.35 $802,500 - $1.37 Million	-50,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$20.02 - $20.02 $1 Million - $1 Million	50,000 New	50,000 $1 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.